Abstract:The beneficial and negative metabolites produced by gut microbiota. The gut microbiota produces all kinds of beneficial or negative metabolites and directly affects the intestinal barrier and gut hormone (GLP‐1 and PYY) release. After entering circulation, those metabolites regulate satiety, insulin release, adipose tissue function, and systemic immunity, thus influencing obesity and energy metabolism. Obesity is often associated with the risk of chronic inflammation and other metabolic diseases, such as diabetes, cardiovascular disease, and cancer. The composition and activity of the gut microbiota play an important role in this process, affecting a range of physiological processes, such as nutrient absorption and energy metabolism. The active gut microbiota can produce a large number of physiologically active substances during the process of intestinal metabolism and reproduction, including short‐chain/long‐chain fatty acids, secondary bile acids, and tryptophan metabolites with beneficial effects on metabolism, as well as negative metabolites, including trimethylamine N‐oxide, delta‐valerobetaine, and imidazole propionate. How gut microbiota specifically affect and participate in metabolic and immune activities, especially the metabolites directly produced by gut microbiota, has attracted extensive attention. So far, some animal and human studies have shown that gut microbiota metabolites are correlated with host obesity, energy metabolism, and inflammation. Some pathways and mechanisms are slowly being discovered. Here, we will focus on the important metabolites of gut microbiota (beneficial and negative), and review their roles and mechanisms in obesity and related metabolic diseases, hoping to provide a new perspective for the treatment and remission of obesity and other metabolic diseases from the perspective of metabolites.

Gut Microbiota: a Potential Manipulator for Host Adipose Tissue and Energy Metabolism.

Dietary Fiber and Its Potential Role in Obesity: A Focus on Modulating the Gut Microbiota

Gut Microbiota and Adipose Tissue Microenvironment Interactions in Obesity

Gut and obesity/metabolic disease: Focus on microbiota metabolites

Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases

The Role of the Gut Microbiome in Energy Balance With a Focus on the Gut-Adipose Tissue Axis

Gut microbial metabolite short-chain fatty acids and obesity

The gut microbiota, obesity and insulin resistance

Contribution of Diet to Gut Microbiota and Related Host Cardiometabolic Health: Diet-Gut Interaction in Human Health.

Gut Microbial-Derived Short Chain Fatty Acids: Impact on Adipose Tissue Physiology

Gut Microbiota in Adipose Tissue Dysfunction Induced Cardiovascular Disease: Role as a Metabolic Organ

[The Intestinal Microbiota and Obesity of the Host].

Gut Microbiota and Obesity: Focus on Hormone Regulation and Appetite Control

Skeletal muscles and gut microbiota-derived metabolites: novel modulators of adipocyte thermogenesis

The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective

Modulation of the gut microbiota-adipose tissue-muscle interactions by prebiotics

The microbiome's influence on obesity: mechanisms and therapeutic potential

Commensal Homeostasis of Gut Microbiota-Host for the Impact of Obesity

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

Gut microbiota and its metabolites: Bridge of dietary nutrients and obesity-related diseases

High Fat Diet, Gut Microbiota and Metabolic Health